Operaciones Carl Zeiss Meditec AG - AFX CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Diferencial | 0.59 | ||||||||
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.017913% | ||||||||
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | -0.004309% | ||||||||
Horario tarifa nocturna | 21:00 (UTC) | ||||||||
Cantidad comercializada mínima | 1 | ||||||||
Divisa | EUR | ||||||||
Margen | 20% | ||||||||
Mercado de valores | Germany | ||||||||
Comisión por operación | 0% |
*Information provided by Capital.com
Cierre previo* | 134.47 |
Abrir* | 134.37 |
Cambio de 1 año* | -12.37% |
Rango del día* | 127.73 - 134.37 |
Rango de 52 semanas | 101.75-152.35 |
Volumen medio (10 días) | 101.01K |
Volumen medio (3 meses) | 1.76M |
Capitalización de mercado | 12.02B |
Ratio P/E | 39.23 |
Acciones en circulación | 89.44M |
Ingresos | 1.96B |
EPS | 3.42 |
Dividendo (Rendimiento %) | 0.81876 |
Beta | 0.64 |
Próxima fecha de resultados | May 9, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Cierre | Change | Change (%) | Apertura | High | Low |
---|---|---|---|---|---|---|
Mar 20, 2023 | 134.47 | -2.25 | -1.65% | 136.72 | 138.66 | 134.37 |
Mar 17, 2023 | 137.51 | 0.20 | 0.15% | 137.31 | 138.11 | 136.07 |
Mar 16, 2023 | 136.92 | 0.45 | 0.33% | 136.47 | 137.07 | 132.67 |
Mar 15, 2023 | 135.07 | -2.94 | -2.13% | 138.01 | 138.21 | 133.07 |
Mar 14, 2023 | 138.06 | 2.24 | 1.65% | 135.82 | 140.16 | 135.62 |
Mar 13, 2023 | 135.77 | 0.30 | 0.22% | 135.47 | 136.32 | 132.47 |
Mar 10, 2023 | 135.47 | 1.15 | 0.86% | 134.32 | 136.07 | 134.17 |
Mar 9, 2023 | 136.37 | 3.65 | 2.75% | 132.72 | 136.52 | 132.22 |
Mar 8, 2023 | 133.27 | -0.20 | -0.15% | 133.47 | 134.42 | 132.32 |
Mar 7, 2023 | 134.82 | -1.85 | -1.35% | 136.67 | 137.41 | 134.32 |
Mar 6, 2023 | 133.62 | 0.25 | 0.19% | 133.37 | 134.12 | 132.47 |
Mar 3, 2023 | 133.52 | 0.85 | 0.64% | 132.67 | 133.81 | 131.87 |
Mar 2, 2023 | 131.57 | 3.94 | 3.09% | 127.63 | 131.97 | 127.43 |
Mar 1, 2023 | 128.53 | 2.75 | 2.19% | 125.78 | 129.23 | 125.53 |
Feb 28, 2023 | 125.78 | -2.80 | -2.18% | 128.58 | 128.93 | 125.33 |
Feb 27, 2023 | 129.43 | -1.25 | -0.96% | 130.68 | 130.88 | 129.23 |
Feb 24, 2023 | 130.13 | -0.60 | -0.46% | 130.73 | 131.97 | 129.08 |
Feb 23, 2023 | 130.18 | -0.40 | -0.31% | 130.58 | 131.57 | 130.03 |
Feb 22, 2023 | 129.78 | -0.10 | -0.08% | 129.88 | 131.02 | 128.58 |
Feb 21, 2023 | 130.48 | -2.44 | -1.84% | 132.92 | 133.32 | 130.38 |
Carl Zeiss Meditec AG Events
Hora (UTC) (UTC) | País | Evento |
---|---|---|
No events scheduled |
- Anual
- Trimestral
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Ingresos totales | 1088.36 | 1189.9 | 1280.86 | 1459.32 | 1335.45 | 1646.79 |
Ingresos | 1088.36 | 1189.9 | 1280.86 | 1459.32 | 1335.45 | 1646.79 |
Coste de los ingresos, total | 508.819 | 533.163 | 570.471 | 627.437 | 589.935 | 679.572 |
Beneficio bruto | 579.546 | 656.733 | 710.389 | 831.884 | 745.517 | 967.213 |
Gastos totales de explotación | 934.033 | 1009.07 | 1083.73 | 1194.66 | 1157.9 | 1273.17 |
Gastos de venta/general/administración Gastos, total | 301.808 | 337.647 | 353.646 | 393.913 | 349.161 | 363.98 |
Investigación y desarrollo | 123.406 | 145.792 | 159.628 | 173.312 | 218.804 | 232.066 |
Ingresos de explotación | 154.332 | 180.83 | 197.13 | 264.659 | 177.552 | 373.614 |
Ingresos por intereses (gastos), netos No operativos | -11.225 | 8.29 | -20.449 | -34.497 | -21.351 | -32.12 |
Otros, netos | -1.146 | -0.564 | 2.502 | -0.304 | 22.516 | -2.444 |
Ingresos netos antes de impuestos | 141.961 | 188.556 | 179.183 | 229.858 | 178.717 | 339.05 |
Ingresos netos después de impuestos | 99.97 | 135.778 | 126.23 | 160.579 | 123.421 | 237.519 |
Intereses menores | -1.64 | -1.333 | 0.233 | -0.823 | -1.036 | -1.243 |
Beneficio neto antes de partidas extra. Elementos | 98.33 | 134.445 | 126.463 | 159.756 | 122.385 | 236.276 |
Ingresos netos | 98.33 | 134.445 | 126.463 | 159.756 | 122.385 | 236.276 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 98.33 | 134.445 | 126.463 | 159.756 | 122.385 | 236.276 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 98.33 | 134.445 | 126.463 | 159.756 | 122.385 | 236.276 |
Beneficio neto diluido | 98.33 | 134.445 | 126.463 | 159.756 | 122.385 | 236.276 |
Promedio ponderado de acciones diluidas | 81.3096 | 85.5867 | 89.4406 | 89.4406 | 89.4406 | 89.4406 |
BPA diluido sin partidas extraordinarias | 1.20933 | 1.57086 | 1.41393 | 1.78617 | 1.36834 | 2.64171 |
Dividends per Share - Common Stock Primary Issue | 0.42 | 0.55 | 0.55 | 0.65 | 0.5 | 0.9 |
BPA normalizado diluido | 1.20933 | 1.46924 | 1.44229 | 1.826 | 1.41621 | 2.62254 |
Gastos (ingresos) extraordinarios | -7.478 | 0 | -2.447 | |||
Other Operating Expenses, Total | -0.058 | -0.015 | 0 |
Q2 2021 | Q3 2021 | Q4 2021 | Q1 2021 | Q2 2022 | |
---|---|---|---|---|---|
Ingresos totales | 398.456 | 430.834 | 448.585 | 410.176 | 445.229 |
Ingresos | 398.456 | 430.834 | 448.585 | 410.176 | 445.229 |
Coste de los ingresos, total | 167.701 | 169.459 | 180.772 | 177.401 | 176.654 |
Beneficio bruto | 230.755 | 261.375 | 267.813 | 232.775 | 268.575 |
Gastos totales de explotación | 309.186 | 310.724 | 357.771 | 335.808 | 342.273 |
Gastos de venta/general/administración Gastos, total | 84.081 | 86.291 | 111.48 | 97.871 | 95.837 |
Investigación y desarrollo | 57.404 | 54.927 | 65.566 | 60.536 | 69.692 |
Gastos (ingresos) extraordinarios | 0 | 0.047 | -0.047 | 0 | 0.09 |
Ingresos de explotación | 89.27 | 120.11 | 90.814 | 74.368 | 102.956 |
Ingresos por intereses (gastos), netos No operativos | -9.995 | -3.625 | -11.82 | -20.181 | -8.662 |
Otros, netos | -0.181 | -0.217 | -1.944 | -0.115 | 25.805 |
Ingresos netos antes de impuestos | 79.094 | 116.268 | 77.05 | 54.072 | 120.099 |
Ingresos netos después de impuestos | 55.173 | 81.199 | 54.819 | 38.009 | 92.095 |
Intereses menores | -0.864 | 0.389 | -0.743 | -0.069 | -1.367 |
Beneficio neto antes de partidas extra. Elementos | 54.309 | 81.588 | 54.076 | 37.94 | 90.728 |
Ingresos netos | 54.309 | 81.588 | 54.076 | 37.94 | 90.728 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 54.309 | 81.588 | 54.076 | 37.94 | 90.728 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 54.309 | 81.588 | 54.076 | 37.94 | 90.728 |
Beneficio neto diluido | 54.309 | 81.588 | 54.076 | 37.94 | 90.728 |
Promedio ponderado de acciones diluidas | 89.0312 | 88.6826 | 89.8211 | 89.5912 | 89.8297 |
BPA diluido sin partidas extraordinarias | 0.61 | 0.92 | 0.60204 | 0.42348 | 1.01 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0.9 | 0 | 0 |
BPA normalizado diluido | 0.61 | 0.92037 | 0.60167 | 0.42348 | 1.01077 |
- Anual
- Trimestral
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total Activo Corriente | 857.463 | 1207.89 | 1251.06 | 1304.33 | 1290.51 | 1604.02 |
Efectivo e inversiones a corto plazo | 8.71 | 8.315 | 7.843 | 22.639 | 6.202 | 7.439 |
Cash | 8.71 | 3.925 | 6.678 | 22.639 | 6.202 | 7.439 |
Efectivo y Equivalentes | 0 | |||||
Total deudores, neto | 627.012 | 935.904 | 981.046 | 1000.34 | 979.93 | 1294.65 |
Accounts Receivable - Trade, Net | 189.244 | 195.256 | 192.33 | 205.789 | 165.158 | 185.94 |
Total Inventory | 208.309 | 234.303 | 248.092 | 268.322 | 286.36 | 286.375 |
Prepaid Expenses | 9.962 | 9.986 | 9.352 | 10.759 | 8.144 | 9.502 |
Other Current Assets, Total | 3.47 | 19.38 | 4.723 | 2.266 | 9.871 | 6.049 |
Total Assets | 1247.73 | 1623.11 | 1662.05 | 2022.13 | 2014.85 | 2395.97 |
Property/Plant/Equipment, Total - Net | 64.509 | 58.696 | 62.632 | 116.752 | 135.265 | 199.555 |
Property/Plant/Equipment, Total - Gross | 171.048 | 174.346 | 196.305 | 280.47 | 320.308 | 379.88 |
Accumulated Depreciation, Total | -106.539 | -115.65 | -133.673 | -163.718 | -185.043 | -180.325 |
Goodwill, Net | 164.578 | 174.313 | 185.638 | 338.094 | 326.51 | 328.714 |
Intangibles, Net | 53.746 | 68.491 | 74.087 | 144.336 | 145.221 | 153.698 |
Long Term Investments | 0.124 | 19.3 | 0.122 | 5.173 | 4.108 | 6.713 |
Note Receivable - Long Term | 13.445 | 14.565 | 9.29 | 10.961 | 9.225 | 9.191 |
Other Long Term Assets, Total | 93.865 | 79.855 | 79.227 | 102.484 | 104.014 | 94.079 |
Total Current Liabilities | 285.897 | 316.078 | 280.18 | 339.6 | 297.584 | 448.118 |
Accounts Payable | 86.531 | 100.463 | 101.437 | 118.12 | 91.679 | 145.465 |
Accrued Expenses | 79.908 | 80.259 | 98.181 | 115.657 | 109.294 | 137.816 |
Notes Payable/Short Term Debt | 22.72 | 5.733 | 15.71 | 0.192 | 0.209 | 0.645 |
Current Port. of LT Debt/Capital Leases | 2.854 | 2.819 | 3.529 | 14.661 | 15.512 | 19.341 |
Other Current Liabilities, Total | 93.884 | 126.804 | 61.323 | 90.97 | 80.89 | 144.851 |
Total Liabilities | 449.893 | 407.731 | 368.588 | 623.69 | 583.133 | 736.641 |
Total Long Term Debt | 7.736 | 3.588 | 7.321 | 151.837 | 140.636 | 178.425 |
Long Term Debt | 1.61 | 0.593 | 0 | 109.009 | 87.543 | 76.496 |
Capital Lease Obligations | 6.126 | 2.995 | 7.321 | 42.828 | 53.093 | 101.929 |
Deferred Income Tax | 10.397 | 8.918 | 5.234 | 18.198 | 17.166 | 15.438 |
Minority Interest | 53.326 | 26.358 | 21.17 | 18.517 | 18.841 | 18.056 |
Other Liabilities, Total | 92.537 | 52.789 | 54.683 | 95.538 | 108.906 | 76.604 |
Total Equity | 797.837 | 1215.38 | 1293.46 | 1398.44 | 1431.72 | 1659.33 |
Common Stock | 81.31 | 89.441 | 89.441 | 89.441 | 89.441 | 89.441 |
Additional Paid-In Capital | 313.863 | 620.137 | 620.137 | 620.137 | 620.137 | 620.137 |
Retained Earnings (Accumulated Deficit) | 458.335 | 555.215 | 632.486 | 744.673 | 808.922 | 1000.48 |
Other Equity, Total | -55.671 | -49.416 | -48.6 | -55.812 | -86.783 | -50.729 |
Total Liabilities & Shareholders’ Equity | 1247.73 | 1623.11 | 1662.05 | 2022.13 | 2014.85 | 2395.97 |
Total Common Shares Outstanding | 81.3096 | 89.4406 | 89.4406 | 89.4406 | 89.4406 | 89.4406 |
Inversiones a corto plazo | 4.39 | 1.165 | 0 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total Activo Corriente | 1451.74 | 1604.02 | 1674.57 | ||
Efectivo e inversiones a corto plazo | 17.352 | 17.918 | 21.589 | ||
Efectivo y Equivalentes | 8.315 | 7.439 | 8.401 | ||
Inversiones a corto plazo | 9.037 | 10.479 | 13.188 | ||
Total deudores, neto | 1140.1 | 1274.3 | 1298.01 | ||
Accounts Receivable - Trade, Net | 164.928 | 185.94 | 156.475 | ||
Total Inventory | 274.078 | 286.375 | 328.867 | ||
Other Current Assets, Total | 20.211 | 25.422 | 26.105 | ||
Total Assets | 2217.7 | 2395.97 | 2526.01 | ||
Property/Plant/Equipment, Total - Net | 189.302 | 199.555 | 205.703 | ||
Goodwill, Net | 323.349 | 328.714 | 379.934 | ||
Intangibles, Net | 144.045 | 153.698 | 163.484 | ||
Long Term Investments | 4.843 | 6.713 | 6.843 | ||
Note Receivable - Long Term | 8.339 | 9.191 | 9.096 | ||
Other Long Term Assets, Total | 96.077 | 94.079 | 86.374 | ||
Total Current Liabilities | 347.866 | 448.118 | 499.258 | ||
Accounts Payable | 123.336 | 145.465 | 140.474 | ||
Accrued Expenses | 92.307 | 127.787 | 109.277 | ||
Notes Payable/Short Term Debt | 0 | 0 | 0 | ||
Current Port. of LT Debt/Capital Leases | 17.876 | 19.341 | 18.97 | ||
Other Current Liabilities, Total | 114.347 | 155.525 | 230.537 | ||
Total Liabilities | 672.152 | 736.641 | 788.612 | ||
Total Long Term Debt | 192.216 | 178.425 | 189.666 | ||
Long Term Debt | 90.194 | 76.496 | 88.588 | ||
Capital Lease Obligations | 102.022 | 101.929 | 101.078 | ||
Deferred Income Tax | 16.932 | 15.438 | 15.035 | ||
Minority Interest | 17.705 | 18.056 | 18.693 | ||
Other Liabilities, Total | 97.433 | 76.604 | 65.96 | ||
Total Equity | 1545.55 | 1659.33 | 1737.39 | ||
Common Stock | 89.441 | 89.441 | 89.441 | ||
Additional Paid-In Capital | 620.137 | 620.137 | 620.137 | ||
Retained Earnings (Accumulated Deficit) | 909.534 | 1000.48 | 1048.65 | ||
Other Equity, Total | -73.565 | -50.729 | -20.833 | ||
Total Liabilities & Shareholders’ Equity | 2217.7 | 2395.97 | 2526.01 | ||
Total Common Shares Outstanding | 89.4406 | 89.4406 | 89.4406 |
- Anual
- Trimestral
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Ingresos netos/Línea de salida | 99.97 | 135.778 | 126.23 | 160.579 | 123.421 | 237.519 |
Efectivo de actividades de explotación | 111.77 | 37.732 | 187.207 | 219.634 | 178.527 | 362.663 |
Efectivo de actividades de explotación | 20.226 | 24.235 | 31.282 | 48.37 | 60.425 | 61.584 |
Partidas no monetarias | 80.32 | 47.269 | 54.526 | 76.373 | 58.691 | 110.074 |
Cash Taxes Paid | 43.792 | 54.73 | 48.364 | 65.07 | 58.964 | 97.908 |
Intereses pagados en efectivo | 1.565 | 1.559 | 1.94 | 1.903 | 1.365 | 1.629 |
Cambios en el capital circulante | -88.746 | -169.55 | -24.831 | -65.688 | -64.01 | -46.514 |
Efectivo de actividades de inversión | 77.332 | -55.931 | -28.874 | -145.846 | -70.947 | -75.2 |
Gastos de capital | -27.917 | -39.022 | -34.756 | -46.711 | -44.986 | -66.101 |
Otras partidas de flujo de caja de inversión, total | 105.249 | -16.909 | 5.882 | -99.135 | -25.961 | -9.099 |
Efectivo procedente de actividades de financiación | -195.021 | 14.494 | -157.237 | -58.637 | -122.961 | -285.889 |
Elementos de flujo de caja de financiación | -160.888 | -259.854 | -104.529 | 4.321 | -48.775 | -223.862 |
Total Cash Dividends Paid | -30.898 | -37.565 | -49.192 | -49.192 | -58.136 | -44.72 |
Emisión (amortización) de deuda, neta | -3.235 | -3.123 | -3.516 | -13.766 | -16.05 | -17.307 |
Efectos del cambio de divisas | 1.588 | -1.08 | 1.657 | 0.81 | -1.056 | -0.337 |
Variación neta de la tesorería | -4.331 | -4.785 | 2.753 | 15.961 | -16.437 | 1.237 |
Emisión (retiro) de acciones, neto | 315.036 | 0 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 101.501 | 130.104 | |||
Cash From Operating Activities | 151.878 | 74.484 | |||
Cash From Operating Activities | 29.924 | 33.045 | |||
Non-Cash Items | 44.673 | 16.671 | |||
Cash Taxes Paid | 41.015 | 61.722 | |||
Cash Interest Paid | 0.67 | 0.679 | |||
Changes in Working Capital | -24.22 | -105.336 | |||
Cash From Investing Activities | -28.769 | -54.311 | |||
Capital Expenditures | -23.26 | -35.335 | |||
Other Investing Cash Flow Items, Total | -5.509 | -18.976 | |||
Cash From Financing Activities | -124.663 | -18.33 | |||
Financing Cash Flow Items | -116.396 | -9.441 | |||
Issuance (Retirement) of Debt, Net | -8.267 | -8.889 | |||
Foreign Exchange Effects | -0.31 | -0.881 | |||
Net Change in Cash | 2.113 | 0.962 |
Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
---|---|---|---|---|---|---|
Carl Zeiss Group | Corporation | 59.14 | 52895153 | 35776 | 2022-11-15 | |
Capital Research Global Investors | Investment Advisor | 4.9912 | 4464153 | -46868 | 2023-02-13 | LOW |
Capital World Investors | Investment Advisor | 1.6403 | 1467117 | 0 | 2023-01-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.1486 | 1027305 | 1286 | 2023-02-28 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 0.8941 | 799668 | -11471 | 2023-01-31 | LOW |
Groupama Asset Management | Investment Advisor | 0.8665 | 775034 | -37628 | 2022-09-30 | LOW |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 0.7614 | 681009 | -125 | 2023-02-28 | LOW |
BlackRock Asset Management Deutschland AG | Investment Advisor | 0.7572 | 677231 | -8165 | 2023-02-28 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.7341 | 656620 | -14037 | 2023-02-28 | LOW |
Allianz Global Investors GmbH | Investment Advisor | 0.6837 | 611545 | -19183 | 2023-01-31 | LOW |
Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 0.5952 | 532334 | 153016 | 2023-02-28 | HIGH |
Candriam Luxembourg S.A. | Investment Advisor | 0.5894 | 527175 | -10543 | 2023-01-31 | HIGH |
La Financière de l'Echiquier | Investment Advisor | 0.5405 | 483394 | -6 | 2022-11-30 | LOW |
Oddo BHF Asset Management S.A.S | Investment Advisor/Hedge Fund | 0.4626 | 413722 | -16606 | 2023-01-31 | LOW |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.442 | 395285 | 17110 | 2023-02-28 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.4095 | 366292 | -451602 | 2022-12-31 | LOW |
Deka Investment GmbH | Investment Advisor/Hedge Fund | 0.332 | 296921 | -10699 | 2023-02-28 | LOW |
Credit Mutuel Asset Management | Investment Advisor | 0.2971 | 265728 | 250534 | 2022-12-31 | HIGH |
Columbia Threadneedle Investments (UK) | Investment Advisor/Hedge Fund | 0.2487 | 222410 | -1214 | 2022-11-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.2357 | 210844 | 1186 | 2023-01-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com GroupTraders
Clientes activos mensualmente
Volumen mensual de inversión
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Carl Zeiss Meditec Company profile
Sobre Carl Zeiss Meditec AG
Carl Zeiss Meditec AG es una empresa alemana de tecnología y dispositivos médicos. Ofrece soluciones completas para diagnosticar y tratar enfermedades oftálmicas, soluciones de visualización para microcirugía y otras tecnologías, como la radioterapia intraoperatoria. La empresa opera en dos segmentos: Dispositivos Oftálmicos y Microcirugía. El segmento de Dispositivos Oftálmicos comprende actividades en el área de la oftalmología, como lentes intraoculares, soluciones de visualización quirúrgica y sistemas de diagnóstico y láser médico. El segmento de microcirugía incluye actividades de neurocirugía, otorrinolaringología, así como las actividades en el campo de la radiación intraoperatoria. La empresa tiene varios centros de producción en Europa, Estados Unidos y Asia.
Industry: | Advanced Medical Equipment & Technology (NEC) |
Göschwitzer Straße 51-52
07745
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 500.000 traders de todo el mundo que eligen operar con Capital.com